Stay updated with the latest abbvie-inc news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on abbvie-inc topics.
The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel of Zydus Lifesciences as its new President, with Glenn Saldanha of Glenmark as Vice President. This leadership transition occurs as the industry navigates GST reforms and strengthens its global position in specialty medicines. The new team aims to drive innovation, patient access, and quality healthcare solutions. The Indian Pharmaceutical Alliance (IPA) has appointed Sharvil Patel, Managing Director of Zydus Lifesciences as i ...Read More >
New Delhi: Industry leaders welcomed the recently announced GST reforms, which reduce the number of tax slabs, stating that it will make tax compliance easier while also directly benefiting consumers through lower prices. Jharkhand Chamber of Commerce Joint Secretary Navjot Alang Rubal said that the reduction of the number of slabs from four to two under the new GST structure is a highly positive step. According to Rubal, this reform will greatly benefit the middle and lower-income groups as t ...Read More >
New Delhi, Sep 5 (PTI) Girish Mathrubootham will step down from his role as Chairman of Freshworks effective December 1, 2025, the Nasdaq-listed SaaS firm said in a filing. The move by Mathrubootham, who is also Freshworks' founder, follows his decision to devote full-time efforts to Together Fund, a venture fund co-founded by him. The Board has appointed Roxanne Austin, Lead Independent Director, to serve as Chairperson of the Board beginning December 1, 2025. "On September 3, 2025, Rathna G ...Read More >
Mumbai: Shares of Glenmark Pharmaceuticals rallied as much as 20% and made a fresh lifetime high on Friday after it announced an exclusive licensing deal between Ichnos Glenmark Innovation (IGI) and AbbVie to develop and commercialise IGI's drug used for oncology and autoimmune diseases. The stock ended at ₹2,175.0 on Friday, up 14.3%. It made a record high of ₹2,284.8 during the day. "The deal marks a turning point for Glenmark and could lead to significant re-rating of the stock," said Ariji ...Read More >
New Delhi, Jul 11 (PTI) Shares of Glenmark Pharmaceuticals Ltd on Friday jumped 10 per cent after the firm said it has signed a deal with AbbVie to commmercialise its underdevelopment drug aimed to treat cancer and autoimmune diseases in an up to USD 2 billion deal, one of the largest transactions in the pharma sector. The stock surged 9.99 per cent to hit its 52-week high as well as the upper circuit limit of Rs 2,095.65 on the BSE. At the NSE, the stock zoomed 10 per cent to Rs 2,094.40 -- i ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Also Read | Bodoland ...Read More >
New Delhi, Jul 10 (PTI) Glenmark Pharmaceuticals Ltd on Thursday said its arm Ichnos Glenmark Innovation, Inc has signed a licensing agreement with AbbVie for commercialisation of its lead investigational asset 'ISB 2001' targeted for treatment of cancer and autoimmune diseases. ISB 2001 has been developed using Ichnos Glenmark Innovation's (IGI) proprietary 'BEAT protein platform' for oncology and autoimmune diseases, Glenmark Pharmaceuticals said in a regulatory filing. Under the agreement, ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.